Healthcare · Active clinical trials
In 2026, Afghanistan had only 2 units active clinical trial, placing it 109th out of 197 countries. This minimal activity reflects a lack of pharmaceutical infrastructure, political instability, and weak regulatory oversight. Research hubs in Kabul and other major cities rarely participate in international multi-center projects. While the global leader, China, conducts thousands of such studies, even single trials in Afghanistan face severe logistical and ethical hurdles.
Data for 2026 · unit: units
Position
#109 / 197
Afghanistan world ranking
Country position on the scale from last to first place for this indicator.
AF
#109
#197#1
Trend
Change over time
Change in indicator over the available period.
0
1990
1
2000
1
2010
2
2020
1
2025
2
2026
Values — units
Comparison
Top countries by Active clinical trials
Where Afghanistan stands in the world ranking.
1
USUSA
12 K
1
CNChina
12 K
3
GBUnited Kingdom
3.5 K
3
JPJapan
3.5 K
5
INIndia
2.5 K
6
FRFrance
1.5 K
6
CACanada
1.5 K
8
DEGermany
1.2 K
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Active clinical trials in Afghanistan — how much?
Based on 2026 data — 2 units. This is rank #109 out of 197 countries.
What is Afghanistan's rank by Active clinical trials?
Afghanistan ranks #109 out of 197 countries in the world ranking by «Active clinical trials».
How has Active clinical trials changed in Afghanistan?
Over the available period the indicator changed from 0 to 2 units.